Net Sales and Income at Each Stage Reach Record Highs
First written in FY2017-Q3. 15 of 41 entries say "Achieved", first in FY2020. Latest entry: FY2027-H1.
The whole theme swung hardest in 2017: 1 of 10 companies on the "Worse" side.
0 other companies' latest entry also says "Achieved".
- FY2027-H1AchievedAnnual report
「The Takahashi Shoten Group, which became consolidated subsidiaries in the previous consolidated fiscal year, also performed well, resulting in record-high revenue, operating profit and ordinary profit. Interim net profit declined year on year due in part to extraordinary losses associated with studio expansion and the impact of a reduction in tax expenses arising from the consolidation of the Takahashi Shoten Group in the previous consolidated fiscal year, but exceeded the plan.」
Including the Takahashi Shoten Group, the interim period produced record-high revenue, operating profit and ordinary profit, while interim net profit fell below the same period of the previous year but exceeded the plan. - 2026-10-08Cited as achievedgamebiz.jp
「主要なクリエイティブ分野（日本）と医療分野を中心に順調に推移し、売上高、営業利益、経常利益において過去最高の業績を達成した。」
第2四半期累計における売上高・営業利益・経常利益の過去最高更新が実績として報じられた。 - FY2026AchievedAnnual report
「In addition, the Takahashi Shoten Group, comprising 5 companies and headed by T&W Office Co., Ltd., which became a consolidated subsidiary in March 2025, performed well. As a result, the group achieved record-high revenue and profit at every level.」
The consolidation of the Takahashi Shoten Group and strong performance in the key creative and medical fields resulted in full-year record highs for revenue and every profit item. - FY2026-H1Profit growth in key fields coexists with company-wide operating profit declineAnnual report
「During the interim consolidated accounting period, the company achieved steady profit growth, mainly in the key Japanese creative and medical fields, and progressed generally as planned. As a result, the group reported revenue of ¥28,092 million (108.7% year on year), operating profit of ¥2,138 million (97.4%), ordinary profit of ¥2,112 million (93.2%), and interim profit attributable to owners of the parent of ¥2,214 million (150.7%).」
The company explains that profit growth was achieved in the key Japanese creative and medical fields, while on a company-wide basis revenue and interim profit attributable to owners of the parent increased, but operating profit and ordinary profit fell below the same period of the previous year. - FY2025-H1Declining profit continues, improvement from the second quarterAnnual report
「In terms of profit, results progressed below both the plan and the previous year’s results due to the group’s largest-ever hiring of new graduates, investment in developing original content scheduled for release in the second half, and other factors. However, profit and loss has been improving since the second quarter, and project acquisition is progressing steadily. The company aims to achieve its full-year plan by monetizing these opportunities going forward.」
Although hiring new graduates and investment in original content development and other factors caused results to fall below the plan and the previous year’s results, the company describes improving profit and loss and progress in acquiring projects from the second quarter. - FY2025-Q1SoftenedAnnual report
「As a result, the group reported revenue of ¥12,854 million (100.9% year on year), operating profit of ¥1,261 million (79.8%), ordinary profit of ¥1,277 million (80.1%), and quarterly profit attributable to owners of the parent of ¥860 million (82.3%) for the cumulative first quarter.」
Revenue exceeded the same period of the previous year, while operating profit, ordinary profit and quarterly profit attributable to owners of the parent fell below it, and the explanation does not indicate an update to record highs. - FY2024SoftenedAnnual report
「Revenue, operating profit and ordinary profit reached record highs.」
For the full year, revenue, operating profit and ordinary profit reached record highs, while profit attributable to owners of the parent was 91.7% of the previous fiscal year, so not all items were described as reaching record highs. - FY2024-Q3AchievedAnnual report
「The company absorbed stepped-up hiring of new graduates and other personnel, mainly in the Japanese creative field, a decline in spot projects for COVID-19 vaccinations in the medical field, and aggressive investment in new businesses. As a result, revenue, operating profit and ordinary profit reached record highs.」
The company absorbed stepped-up hiring of new graduates, a decline in vaccination projects and investment in new businesses, resulting in record highs for cumulative quarterly revenue, operating profit and ordinary profit. Net profit attributable to owners of the parent was below the same period of the previous year. - FY2024-Q2AdvancedAnnual report
「The company absorbed stepped-up hiring of new graduates and other personnel, mainly in the Japanese creative field, a decline in spot projects for COVID-19 vaccinations in the medical field, and aggressive business investment, including the establishment of new group companies. As a result, revenue, operating profit and ordinary profit reached record highs for the half year.」
The company absorbed stepped-up hiring of new graduates, a decline in spot vaccination projects and investment including the establishment of new group companies, resulting in half-year record highs for revenue, operating profit and ordinary profit. Quarterly profit attributable to owners of the parent was below the same period of the previous year, so not all items reached record highs. - FY2024-Q1SoftenedAnnual report
「Revenue reached a quarterly record high. However, personnel and training costs increased due to stepped-up hiring of new graduates and other personnel, mainly in the Japanese creative field, to meet strong demand. In addition, spot projects for COVID-19 vaccinations in the medical field declined, and the company made aggressive business investments, including the establishment of new group companies. As a result, every profit item fell below the previous year’s results, although results progressed as planned.」
Quarterly revenue reached a record high, but every profit item fell below the previous year’s results due to hiring costs, a decline in vaccination projects and investment in new businesses, limiting the record-high designation to revenue. - FY2023AchievedAnnual report
「Results for the consolidated fiscal year reached record highs in every item.」
For the full year, revenue, operating profit, ordinary profit and profit attributable to owners of the parent all reached record highs. - FY2023-Q3AchievedAnnual report
「Results for the cumulative third quarter reached record highs in every item.」
For the cumulative third quarter, revenue, operating profit, ordinary profit and quarterly profit attributable to owners of the parent all reached record highs. - FY2023-Q2AchievedAnnual report
「In particular, the production business in the Japanese creative field, which is central to the group, and the agency business in the medical field performed well. As a result, results for the cumulative second quarter reached record highs in every item.」
The company states that, during the cumulative second quarter, revenue, operating profit, ordinary profit and quarterly profit attributable to owners of the parent all reached record highs. - FY2023-Q1AchievedAnnual report
「In particular, the production business and rights-management business involving e-books and YouTube in the Japanese creative field, which is central to the group, as well as the agency businesses in the Japanese creative and medical fields, performed well. As a result, results for the cumulative first quarter reached record highs in every item.」
During the cumulative first quarter, revenue, operating profit, ordinary profit and quarterly profit attributable to owners of the parent all reached record highs. - FY2022AchievedAnnual report
「Of the 18 companies comprising the consolidated group, 15 achieved higher profit than in the previous fiscal year, and results for the consolidated fiscal year reached record highs in every item.」
Revenue was ¥41,799 million, operating profit was ¥3,411 million, ordinary profit was ¥3,419 million, and profit attributable to owners of the parent was ¥2,224 million, achieving record highs in every item. - FY2022-Q2AdvancedAnnual report
「Although the impact of COVID-19 remained in some areas, the group’s results for the cumulative second quarter progressed steadily, exceeding both the results for the same period of the previous year and the plan announced at the beginning of the period, due to thorough, detailed responses to clients. The impact of COVID-19 included the continued cancellation of events in locations throughout Japan in the medical business and delays in the recovery of demand in the recruitment business, particularly in the accounting and legal sectors. However, the agency business in the core Japanese creative and medical fields, the production business in the Japanese creative field, and the rights-management business involving e-books and YouTube performed well, resulting in record-high results.」
Despite the continuing impact of the infectious disease, results exceeded the plan and the same period of the previous year, producing record-high cumulative quarterly results. - FY2022-Q1RestatedAnnual report
「As a result, the group reported revenue of ¥10,599 million (111.7% year on year), operating profit of ¥1,230 million (117.3%), ordinary profit of ¥1,247 million (117.3%), and quarterly profit attributable to owners of the parent of ¥881 million (124.1%) for the cumulative first quarter.」
The company has maintained results in which revenue, operating profit, ordinary profit and quarterly profit attributable to owners of the parent all exceeded the same period of the previous year. - FY2021AchievedAnnual report
「The company achieved record-high results in revenue and every profit item.」
The company states that, despite the impact of COVID-19 and failure to meet the initial plan, full-year revenue and every profit item reached record highs. - FY2021-Q3RestatedAnnual report
「As a result, the group reported revenue of ¥27,557 million (112.3% year on year), operating profit of ¥1,909 million (115.3%), ordinary profit of ¥1,938 million (116.7%), and quarterly profit attributable to owners of the parent of ¥1,263 million (122.9%) for the cumulative third quarter.」
The company has maintained results in which revenue, operating profit, ordinary profit and quarterly profit attributable to owners of the parent all exceeded the same period of the previous year. - FY2021-Q2Ahead of planAnnual report
「The company continued efforts to improve the efficiency of selling, general and administrative expenses by reviewing how officers and employees work and thoroughly eliminating waste. As a result, profit progressed above plan.」
Although the company does not describe this as an update to record highs, it explains that continued cost-efficiency initiatives resulted in profit progressing above plan. - FY2021-Q1RestatedAnnual report
「As a result, the group reported revenue of ¥9,486 million (115.2% year on year), operating profit of ¥1,049 million (133.2%), ordinary profit of ¥1,062 million (134.5%), and quarterly profit attributable to owners of the parent of ¥709 million (140.1%) for the cumulative first quarter.」
The company confirms that revenue, operating profit, ordinary profit and quarterly profit attributable to owners of the parent all exceeded the same period of the previous year. - FY2020AchievedAnnual report
「The company achieved significant year-on-year growth in every profit item, producing record-high results.」
The company states that, moving beyond the previous fiscal year’s limitation of the record-high expression to a company-wide basis, revenue and every profit item exceeded the previous fiscal year, resulting in record-high performance. - FY2020-Q3RestatedAnnual report
「Results for the cumulative third quarter exceeded those of the same period of the previous year in revenue and every profit item, and progressed generally as planned.」
The company maintains its explanation that revenue and every profit item exceeded the same period of the previous year and progressed generally as planned. - FY2020-Q2RestatedAnnual report
「Results for the cumulative second quarter exceeded those of the same period of the previous year in revenue and every profit item, and progressed generally as planned.」
The company maintains its explanation that results exceeded the same period of the previous year and progressed generally as planned, but does not use the expression “record high.” - FY2020-Q1SoftenedAnnual report
「Results for the cumulative first quarter exceeded those of the same quarter of the previous year and progressed as planned.」
Rather than using the previous expression “record high,” the company only explains that results exceeded the same quarter of the previous year and progressed as planned. - FY2019SoftenedAnnual report
「During the previous fiscal year, the company absorbed the negative impact of its sub-subsidiary CREEK & RIVER ENTERTAINMENT Co., Ltd. changing from a consolidated subsidiary to an equity-method associate, and expanded steadily across all segments, resulting in record-high revenue. In terms of profit, however, results were below those of the previous fiscal year due to one-time costs associated with relocating and consolidating group offices in the Tokyo area in October 2018, one-time costs resulting from a change in the method of recording retirement benefit obligations due to an increase in personnel, and investments in newly established and newly consolidated businesses.」
For the full year, the expression “record high” was limited to revenue, while profit fell below the previous fiscal year due to one-time costs and investment in new businesses. - FY2019-Q3SoftenedAnnual report
「Revenue during the cumulative third quarter exceeded the same period of the previous year and progressed steadily. In terms of profit, selling, general and administrative expenses increased due to staff reinforcements in response to higher demand in existing business divisions, the launch of a new agency business, and the consolidation of Claytechworks Co., Ltd. as a subsidiary in July 2018. However, the number of high-margin commissioned production projects at the production studio increased, and the agency business, including temporary staffing, grew, absorbing the one-time costs associated with relocating and consolidating group offices in October 2018. As a result, results exceeded the same period of the previous year and reached record highs.」
Although the expression “record high” is used for the Japanese creative business, company-wide operating profit, ordinary profit and profit attributable to owners of the parent were below the same period of the previous year, limiting the scope compared with the previous expression of company-wide record highs. - FY2019-Q2RestatedAnnual report
「Selling, general and administrative expenses increased due to staff reinforcements in response to higher demand in existing business divisions, the launch of a new agency business, and the consolidation of Claytechworks Co., Ltd. as a subsidiary in July 2018. However, the number of high-margin commissioned production projects at the production studio increased, and the agency business, including temporary staffing, grew. As a result, results exceeded the same period of the previous year and reached record highs.」
Despite factors increasing expenses, the Japanese creative business achieved record-high results due to high-margin commissioned production projects and growth in the agency business. - FY2019-Q1RestatedAnnual report
「Revenue remained solid during the cumulative first quarter, exceeding the same period of the previous year and progressing steadily. In terms of profit, selling, general and administrative expenses increased due to staff reinforcements in response to higher demand in existing business divisions, the launch of a new agency business, and stronger initiatives in new markets such as VR and AI. However, the number of high-margin commissioned production projects at the production studio increased, among other factors, and results exceeded the same period of the previous year, reaching record highs.」
In the Japanese creative business, despite higher selling, general and administrative expenses, results exceeded the same period of the previous year and reached record highs, due in part to an increase in high-margin commissioned production projects. - FY2018RestatedAnnual report
「In terms of profit, in the Japanese creative business, selling, general and administrative expenses increased as the company strategically hired personnel to reinforce staffing for existing businesses and launch new businesses. However, the number of high-margin commissioned projects at the production studio increased, and the medical business continued to grow. As a result, results exceeded the plan announced at the beginning of the period and reached record highs.」
High-margin commissioned projects and growth in the medical business exceeded the higher costs from hiring and investment in new businesses, resulting in results above plan and record-high performance. - FY2018-Q3RestatedAnnual report
「In terms of profit, in the Japanese creative business, selling, general and administrative expenses increased as the company strategically hired personnel to reinforce staffing for existing businesses and launch new businesses. However, the number of high-margin commissioned projects at the production studio increased, and the medical business continued to grow. As a result, profit margins improved significantly, producing record-high results.」
The company reconfirms that the increase in commissioned projects exceeded the higher costs from hiring, and that growth in the medical business improved profit margins and produced record-high results. - FY2018-Q1RestatedAnnual report
「Profit margins improved significantly, producing record-high results.」
The company also reports a significant improvement in profit margins and record-high results for the first quarter. - FY2017RestatedAnnual report
「Both revenue and profit at every level exceeded the previous consolidated fiscal year, producing record-high results.」
The company reconfirms that full-year revenue and profit at every level exceeded the previous year and reached record highs, led by the Japanese creative and medical businesses. - FY2017-Q3First statedAnnual report
「Although the Korean creative business was a negative factor due to the impact of the stronger yen and weaker won, among other factors, business grew steadily, led by the Japanese creative business and the medical business. As a result, both revenue and profit at every level exceeded the same period of the previous year, producing record-high results.」
Despite the foreign-exchange impact on the Korean business, revenue and profit at every level exceeded the same period of the previous year, led by the Japanese creative and medical businesses, reaching record highs.